These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11362972)

  • 1. An interview with Charles A.B. Boucher, MD, PhD. Interview by Mark Mascolini.
    Boucher CA
    J Int Assoc Physicians AIDS Care; 1995 Nov; 1(10):30-5. PubMed ID: 11362972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3TC/AZT: just another combination.
    GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamivudine (3TC) approved for combination use with AZT.
    James JS
    AIDS Treat News; 1995 Dec; (no 236):1-5. PubMed ID: 11363049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conference looks at HIV drug resistance.
    Chang HE
    GMHC Treat Issues; 1995 Sep; 9(9):6-8. PubMed ID: 11362910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease inhibitors and prevention of cross resistance.
    Levin J
    AIDS Treat News; 1995 Oct; (no 232):1-3. PubMed ID: 11362875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3TC approved: now for the tough questions.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):6-8. PubMed ID: 11363101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease inhibitors and nucleosides: how many? when? An interview with Stefano Vella, MD. Interview by Mark Mascolini.
    Vella S
    J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):12-8. PubMed ID: 11363089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Lisbon traviata. Are clinicians ready to sing addio to monotherapy and libiamo to combinations?
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):10-20, 22. PubMed ID: 11362792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A closer look at 3TC. Interview by Mark Mascolini.
    Rubin M
    J Int Assoc Physicians AIDS Care; 1995 Jul; 1(6):21-5. PubMed ID: 11362724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral resistance and the selection of antiretroviral combinations.
    Larder BA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S28-33. PubMed ID: 8595505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What we know about anti-HIV drugs.
    Treat Rev; 1995 May; (no 18):3-4. PubMed ID: 11362592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral drug resistance.
    Japour AJ
    AIDS Clin Care; 1995 Aug; 7(8):63-5, 67. PubMed ID: 11362787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished selection for thymidine-analog mutations associated with the presence of M184V in Ethiopian children infected with HIV subtype C receiving lamivudine-containing therapy.
    Averbuch D; Schapiro JM; Lanier ER; Gradstein S; Gottesman G; Kedem E; Einhorn M; Grisaru-Soen G; Ofir M; Engelhard D; Grossman Z
    Pediatr Infect Dis J; 2006 Nov; 25(11):1049-56. PubMed ID: 17072129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PHS recommends preventive drugs for HIV exposures.
    OR Manager; 1996 Aug; 12(8):1, 6. PubMed ID: 10161372
    [No Abstract]   [Full Text] [Related]  

  • 15. A quarter-century of antiviral therapy.
    Merigan TC
    N Engl J Med; 1995 Dec; 333(25):1704-5. PubMed ID: 7477225
    [No Abstract]   [Full Text] [Related]  

  • 16. Absence of zidovudine resistance in antiretroviral-naive patients following zidovudine/lamivudine/protease inhibitor combination therapy: virological evaluation of the AVANTI 2 and AVANTI 3 studies.
    Maguire M; Gartland M; Moore S; Hill A; Tisdale M; Harrigan R; Kleim JP
    AIDS; 2000 Jun; 14(9):1195-201. PubMed ID: 10894284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of combined zidovudine and lamivudine compared with that of combined zidovudine, lamivudine and nelfinavir in asymptomatic and early symptomatic HIV-infected children.
    Moolasart P; Likanonsakul S
    Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):280-7. PubMed ID: 12236426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease inhibitors.
    Treat Rev; 1995; (no 19):2. PubMed ID: 11362753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus 1 strains resistant to nucleoside inhibitors of reverse transcriptase in isolates from the Czech Republic as monitored by line probe assay and nucleotide sequencing.
    Reinis M; Vandasová J; Stanková M; Linka M; Brůcková M
    Acta Virol; 2001; 45(5-6):279-86. PubMed ID: 12083326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination treatment and single drugs: interview with Margaret Poscher, M.D. Interview by John S. James.
    Poscher M
    AIDS Treat News; 1995 Jul; (no 226):2-4 contd. PubMed ID: 11362613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.